| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.29 | 4e-06 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.31 | 5e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.28 | 1e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |